Interpretation and utilization of disease burden assessment indicators_Chinese Journal of Evidence-Based Medicine

Authors：

HU Xiaoye ^1,2,3 , LIANG Shanshan ^1,2,3 , ZHANG Xiaolin ⁴ , WANG Yongsheng ^1,2,3 , CUI Lu ^1,2,3 , HUANG Jiayi ^1,2,3 , LIANG Cui ^1,2,3 , WANG Hanbin ^1,2,3 , NIAN Tao ^1,2,3 ,  YANG Kehu ^1,2,3 ,  LI Xiuxia ^1,2,3

1. Health Technology Assessment Center/Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou 730000, P. R. China;
2. Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, P. R. China;
3. Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province, Lanzhou 730000, P. R. China;
4. Imperial College London, London SW7 2AZ, UK;

Corresponding?author：

YANG Kehu, Email: yangkh-ebm@lzu.edu.cn; LI Xiuxia, Email: lixiuxia@lzu.edu.cn

Keywords：

Disease burden; DALY; Epidemiology; Public health; Healthy life

DOI：

10.7507/1672-2531.202409025

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To summarize and categorize the epidemiological evaluation indicators of disease burden, and to explore and analyze the research gaps in the existing evaluation indicators of disease burden. Methods The CNKI, WanFang Data, VIP, CBM, PubMed, Embase, Web of Science and Cochrane Library databases were searched by computer to obtain qualitative studies on evaluation indicators of disease burden. The search time limit was from the establishment of the database to October 2023. CASP was used to evaluate the methodological quality of the included studies, and thematic analysis was used to summarize the evaluation indicators of disease burden by NVivo 12 software. Results A total of 19 studies were included, of which 10 studies were of high quality and 9 studies were of medium quality. The evaluation indicators of disease burden were summarized into two three-level core themes: positive indicators and negative indicators. Five second-level analytic themes were used: disease indicators, life loss indicators, life expectancy indicators, cause removal indicators and health status indicators. Twenty-nine level-1 descriptive themes. Conclusion The evaluation indicators of disease burden have their respective scopes of application and limitations. It is necessary to continue strengthening the construction of a comprehensive evaluation index system for disease burden, so that it is comparable and reliable, can adapt to local calculation weights, and covers both family burden and social burden.

Citation： HU Xiaoye, LIANG Shanshan, ZHANG Xiaolin, WANG Yongsheng, CUI Lu, HUANG Jiayi, LIANG Cui, WANG Hanbin, NIAN Tao, YANG Kehu, LI Xiuxia. Interpretation and utilization of disease burden assessment indicators. Chinese Journal of Evidence-Based Medicine, 2025, 25(1): 118-124. doi: 10.7507/1672-2531.202409025 Copy

1.	Kristjuhan U. Postponing aging and prolonging life expectancy with the knowledge-based economy. Rejuvenation Res, 2012, 15(2): 132-133.
2.	World Health Organization. The world health report. 1997.
3.	李茜瑤, 周瑩, 黃輝, 等. 疾病負擔研究進展. 中國公共衛生, 2018, 34(5): 777-780.
4.	GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet, 2024, 403(10440): 2204-2256.
5.	黃崇斐, 拜爭剛, 吳淑婷, 等. 定性系統評價的撰寫方法介紹. 中國循證醫學雜志, 2015, 15(9): 1106-1111.
6.	文煜, 武振宇. 疾病負擔評價指標的實證分析—以傷殘調整壽命年為例. 衛生職業教育, 2023, 41(7): 156-160.
7.	黎倩欣, 周智華, 梁珊珊, 等. 大數據技術背景下疾病負擔應用分析. 中國循證醫學雜志, 2023, 23(3): 351-356.
8.	孫秋芬, 呂筠, 李立明. 期望壽命相關指標的發展和應用. 中華流行病學雜志, 2021, 42(9): 1677-1682.
9.	董惠玲, 吳炳義, 武繼磊, 等. 健康預期壽命與傷殘調整生命年內在關聯與差異. 中國公共衛生, 2020, 36(11): 1645-1650.
10.	苗鑫蕾, 張翔, 孟群. 沙利文法中健康期望壽命的測算指標. 中國衛生統計, 2019, 36(6): 906-908.
11.	周尚成, 陳輝, 易衛兵. 應用傷殘調整生命年評價疾病負擔的方法學探究. 中國慢性病預防與控制, 2011, 19(3): 320-323.
12.	詹一, 俞敏. 健康期望壽命的計算方法與應用. 疾病監測, 2011, 26(12): 1004-1008.
13.	和沛森, 吳群紅, 郝艷華, 等. 全球疾病負擔測算指標: 傷殘調整生命年的探討. 中國衛生經濟, 2011, 30(10): 78-79.
14.	王建生, 金水高. 去病因健康調整期望壽命—一個新的疾病負擔評價指標. 中華預防醫學雜志, 2009, 43(8): 655-658.
15.	王書平, 時景璞. 疾病負擔評價常用指標及其應用. 遼寧醫學雜志, 2007, (5): 321-324.
16.	郭世成, 梁曉峰, 左樹巖. 疾病負擔研究—失能調整壽命年指標的應用. 中國計劃免疫, 2006, (1): 72-75.
17.	賈鐵武, 周曉農. 疾病負擔(DALY)的評價與應用. 中國寄生蟲學與寄生蟲病雜志, 2005, (5): 304-308.
18.	王斌, 徐凌中. 衡量疾病負擔的新指標—DALY. 中國衛生資源, 2002, (5): 230-231.
19.	莊潤森, 王聲湧. DALYs及其在疾病負擔與成本效果分析中的應用. 廣東衛生防疫, 2001, (3): 19-23.
20.	徐凌中, 柳麗華, 王永杰, 等. 效用指標的測量方法及其研究進展. 國外醫學(衛生經濟分冊), 2001, 18(2): 88-92.
21.	謝立, 舒麗萍, 施侶元, 等. 減壽分析評價指標研究進展. 國外醫學(社會醫學分冊), 2000, (2): 58-61.
22.	龐琳, 許群, 金水高. 健康壽命年—一個新的測量疾病負擔的指標. 衛生研究, 1999, (2): 63-65.
23.	夏毅, 龔幼龍, 顧杏元, 等. 疾病負擔的測量指標—DALY(一). 中國衛生統計, 1998, (3): 53-54.
24.	May AM, Struijk EA, Fransen HP, et al. The impact of a healthy lifestyle on disability-adjusted life years: a prospective cohort study. BMC Med, 2015, 13: 39.
25.	張普洪, 武陽豐, 金水高, 等. 個體失能調整損失年的建立和探討. 中華預防醫學雜志, 2004, (2): 47-50.
26.	Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ, 1999, 319(7222): 1423-1425.
27.	呂繁. 疾病家庭負擔和社會負擔研究. 北京: 中國協和醫科大學, 2000.

1. Kristjuhan U. Postponing aging and prolonging life expectancy with the knowledge-based economy. Rejuvenation Res, 2012, 15(2): 132-133.
2. World Health Organization. The world health report. 1997.
3. 李茜瑤, 周瑩, 黃輝, 等. 疾病負擔研究進展. 中國公共衛生, 2018, 34(5): 777-780.
4. GBD 2021 Forecasting Collaborators. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet, 2024, 403(10440): 2204-2256.
5. 黃崇斐, 拜爭剛, 吳淑婷, 等. 定性系統評價的撰寫方法介紹. 中國循證醫學雜志, 2015, 15(9): 1106-1111.
6. 文煜, 武振宇. 疾病負擔評價指標的實證分析—以傷殘調整壽命年為例. 衛生職業教育, 2023, 41(7): 156-160.
7. 黎倩欣, 周智華, 梁珊珊, 等. 大數據技術背景下疾病負擔應用分析. 中國循證醫學雜志, 2023, 23(3): 351-356.
8. 孫秋芬, 呂筠, 李立明. 期望壽命相關指標的發展和應用. 中華流行病學雜志, 2021, 42(9): 1677-1682.
9. 董惠玲, 吳炳義, 武繼磊, 等. 健康預期壽命與傷殘調整生命年內在關聯與差異. 中國公共衛生, 2020, 36(11): 1645-1650.
10. 苗鑫蕾, 張翔, 孟群. 沙利文法中健康期望壽命的測算指標. 中國衛生統計, 2019, 36(6): 906-908.
11. 周尚成, 陳輝, 易衛兵. 應用傷殘調整生命年評價疾病負擔的方法學探究. 中國慢性病預防與控制, 2011, 19(3): 320-323.
12. 詹一, 俞敏. 健康期望壽命的計算方法與應用. 疾病監測, 2011, 26(12): 1004-1008.
13. 和沛森, 吳群紅, 郝艷華, 等. 全球疾病負擔測算指標: 傷殘調整生命年的探討. 中國衛生經濟, 2011, 30(10): 78-79.
14. 王建生, 金水高. 去病因健康調整期望壽命—一個新的疾病負擔評價指標. 中華預防醫學雜志, 2009, 43(8): 655-658.
15. 王書平, 時景璞. 疾病負擔評價常用指標及其應用. 遼寧醫學雜志, 2007, (5): 321-324.
16. 郭世成, 梁曉峰, 左樹巖. 疾病負擔研究—失能調整壽命年指標的應用. 中國計劃免疫, 2006, (1): 72-75.
17. 賈鐵武, 周曉農. 疾病負擔(DALY)的評價與應用. 中國寄生蟲學與寄生蟲病雜志, 2005, (5): 304-308.
18. 王斌, 徐凌中. 衡量疾病負擔的新指標—DALY. 中國衛生資源, 2002, (5): 230-231.
19. 莊潤森, 王聲湧. DALYs及其在疾病負擔與成本效果分析中的應用. 廣東衛生防疫, 2001, (3): 19-23.
20. 徐凌中, 柳麗華, 王永杰, 等. 效用指標的測量方法及其研究進展. 國外醫學(衛生經濟分冊), 2001, 18(2): 88-92.
21. 謝立, 舒麗萍, 施侶元, 等. 減壽分析評價指標研究進展. 國外醫學(社會醫學分冊), 2000, (2): 58-61.
22. 龐琳, 許群, 金水高. 健康壽命年—一個新的測量疾病負擔的指標. 衛生研究, 1999, (2): 63-65.
23. 夏毅, 龔幼龍, 顧杏元, 等. 疾病負擔的測量指標—DALY(一). 中國衛生統計, 1998, (3): 53-54.
24. May AM, Struijk EA, Fransen HP, et al. The impact of a healthy lifestyle on disability-adjusted life years: a prospective cohort study. BMC Med, 2015, 13: 39.
25. 張普洪, 武陽豐, 金水高, 等. 個體失能調整損失年的建立和探討. 中華預防醫學雜志, 2004, (2): 47-50.
26. Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ, 1999, 319(7222): 1423-1425.
27. 呂繁. 疾病家庭負擔和社會負擔研究. 北京: 中國協和醫科大學, 2000.

Chinese Journal of Evidence-Based Medicine

Interpretation and utilization of disease burden assessment indicators

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content